IL163847A0 - Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions - Google Patents
Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditionsInfo
- Publication number
- IL163847A0 IL163847A0 IL16384703A IL16384703A IL163847A0 IL 163847 A0 IL163847 A0 IL 163847A0 IL 16384703 A IL16384703 A IL 16384703A IL 16384703 A IL16384703 A IL 16384703A IL 163847 A0 IL163847 A0 IL 163847A0
- Authority
- IL
- Israel
- Prior art keywords
- ccr
- antagonist
- treatment
- inflammatory conditions
- urea derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207432.6A GB0207432D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
| PCT/EP2003/003345 WO2003082293A1 (en) | 2002-03-28 | 2003-03-27 | Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163847A0 true IL163847A0 (en) | 2005-12-18 |
Family
ID=9933984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16384703A IL163847A0 (en) | 2002-03-28 | 2003-03-27 | Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7531651B2 (de) |
| EP (1) | EP1487456B1 (de) |
| JP (1) | JP2005526808A (de) |
| KR (1) | KR20040099375A (de) |
| CN (1) | CN1642554A (de) |
| AR (1) | AR039179A1 (de) |
| AT (1) | ATE317698T1 (de) |
| AU (1) | AU2003226761A1 (de) |
| BR (1) | BR0308480A (de) |
| CA (1) | CA2479912A1 (de) |
| DE (1) | DE60303603T2 (de) |
| ES (1) | ES2258724T3 (de) |
| GB (1) | GB0207432D0 (de) |
| IL (1) | IL163847A0 (de) |
| IS (1) | IS7432A (de) |
| MX (1) | MXPA04009456A (de) |
| NO (1) | NO20044323L (de) |
| PL (1) | PL372623A1 (de) |
| RU (1) | RU2004126948A (de) |
| TW (1) | TW200407145A (de) |
| WO (1) | WO2003082293A1 (de) |
| ZA (1) | ZA200407463B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015500221A (ja) | 2011-12-01 | 2015-01-05 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 眼疾患の治療および予防方法 |
| FR3022142B1 (fr) | 2014-06-16 | 2019-07-12 | Universite Paul Sabatier - Toulouse Iii | Inhibition de la chimiokine ccl7 ou de son recepteur ccr3 pour le traitement et le diagnostic du cancer de la prostate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970703301A (ko) | 1994-05-18 | 1997-07-03 | 쇼오다 오사무 | 신규 디아미노메틸리덴 유도체(novel diamincmethylidene derivative) |
| CA2350903A1 (en) * | 1998-11-20 | 2000-06-02 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives-ccr-3 receptor antagonists |
| IL155092A0 (en) | 2000-09-29 | 2003-10-31 | Glaxo Group Ltd | Compounds useful in the treatment of inflammatory diseases |
-
2002
- 2002-03-28 GB GBGB0207432.6A patent/GB0207432D0/en not_active Ceased
-
2003
- 2003-03-26 TW TW092106768A patent/TW200407145A/zh unknown
- 2003-03-27 MX MXPA04009456A patent/MXPA04009456A/es unknown
- 2003-03-27 PL PL03372623A patent/PL372623A1/xx not_active Application Discontinuation
- 2003-03-27 BR BR0308480-9A patent/BR0308480A/pt not_active Application Discontinuation
- 2003-03-27 DE DE60303603T patent/DE60303603T2/de not_active Expired - Lifetime
- 2003-03-27 AT AT03745298T patent/ATE317698T1/de not_active IP Right Cessation
- 2003-03-27 CA CA002479912A patent/CA2479912A1/en not_active Abandoned
- 2003-03-27 EP EP03745298A patent/EP1487456B1/de not_active Expired - Lifetime
- 2003-03-27 ES ES03745298T patent/ES2258724T3/es not_active Expired - Lifetime
- 2003-03-27 KR KR10-2004-7015442A patent/KR20040099375A/ko not_active Application Discontinuation
- 2003-03-27 JP JP2003579830A patent/JP2005526808A/ja active Pending
- 2003-03-27 AR ARP030101092A patent/AR039179A1/es unknown
- 2003-03-27 IL IL16384703A patent/IL163847A0/xx unknown
- 2003-03-27 AU AU2003226761A patent/AU2003226761A1/en not_active Abandoned
- 2003-03-27 RU RU2004126948/04A patent/RU2004126948A/ru not_active Application Discontinuation
- 2003-03-27 US US10/509,521 patent/US7531651B2/en not_active Expired - Fee Related
- 2003-03-27 CN CNA038073641A patent/CN1642554A/zh active Pending
- 2003-03-27 WO PCT/EP2003/003345 patent/WO2003082293A1/en active IP Right Grant
-
2004
- 2004-08-31 IS IS7432A patent/IS7432A/is unknown
- 2004-09-16 ZA ZA200407463A patent/ZA200407463B/en unknown
- 2004-10-12 NO NO20044323A patent/NO20044323L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200407463B (en) | 2005-10-12 |
| ES2258724T3 (es) | 2006-09-01 |
| EP1487456B1 (de) | 2006-02-15 |
| DE60303603T2 (de) | 2006-10-26 |
| TW200407145A (en) | 2004-05-16 |
| CN1642554A (zh) | 2005-07-20 |
| PL372623A1 (en) | 2005-07-25 |
| JP2005526808A (ja) | 2005-09-08 |
| NO20044323L (no) | 2004-10-27 |
| US20060089497A1 (en) | 2006-04-27 |
| BR0308480A (pt) | 2005-01-18 |
| CA2479912A1 (en) | 2003-10-09 |
| AR039179A1 (es) | 2005-02-09 |
| ATE317698T1 (de) | 2006-03-15 |
| WO2003082293A1 (en) | 2003-10-09 |
| US7531651B2 (en) | 2009-05-12 |
| IS7432A (is) | 2004-08-31 |
| KR20040099375A (ko) | 2004-11-26 |
| DE60303603D1 (de) | 2006-04-20 |
| MXPA04009456A (es) | 2005-01-25 |
| EP1487456A1 (de) | 2004-12-22 |
| GB0207432D0 (en) | 2002-05-08 |
| RU2004126948A (ru) | 2005-07-10 |
| AU2003226761A1 (en) | 2003-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176308A0 (en) | Maleate salts of a quinazoline derivative useful as an antiangiogenic agent | |
| HK1139681A1 (en) | Salts of valsartan | |
| IL157659A0 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IL173768A0 (en) | 1-(2-amino-benzol)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses | |
| ZA200500680B (en) | Quinoline derivatives and their use as mycrobacterial inhibitors | |
| IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
| PL370478A1 (en) | Aminoindazole derivatives as protein-kinase inhibitors | |
| IL169323A0 (en) | Pyrazole-derivatives as factor xa inhibitors | |
| IS7913A (is) | Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar | |
| HK1089167A1 (en) | 2-pyridone derivatives as netrophil elastase inhibitors and their use 2- | |
| IL165887A0 (en) | Novel tetrahydropyridine derivatives as renin inhibitors | |
| IL178100A0 (en) | 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| AU2003302238A8 (en) | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors | |
| HK1108435A1 (en) | Hydantoin derivatives useful as metalloproteinase inhibitors | |
| IL161165A0 (en) | Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist | |
| AU2003226759A1 (en) | Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions | |
| AP1963A (en) | Substituted pyrrole derivatives and their use as HMG-co inhibitors | |
| HUP0401641A3 (en) | Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors | |
| IL174040A0 (en) | Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases | |
| IL163847A0 (en) | Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions | |
| IL172615A0 (en) | N-{4'-substituted piperazine -1-sulfonylmethyl-alkyl}-n- hydroxyformamide compounds as metalloproteinase inhibitors | |
| EP1532103A4 (de) | Verwendung von verbindungen mit einem aminkern bei der herstellung eines medikaments, das sich für die behandlung von mit faktor-viia-assoziierten leiden eignet | |
| AU2003242559A8 (en) | Alkylaminosiloxanes as corrosion inhibitors | |
| AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors |